In this article
The Serum Institute of India Ltd., which is producing the coronavirus vaccine developed by AstraZeneca Plc and the University of Oxford, expects the Indian government to sign a formal supply and pricing agreement within days.
Officials in New Delhi have informally agreed that the first 100 million vaccines will be purchased and priced at 200 rupees ($2.74), Serum’s Chief Executive Officer Adar Poonawalla said in an interview on Sunday. The vaccine will cost 1,000 rupees on the private market, which may be approved “in two or three months,” he said.
India this weekend granted emergency approval for the Astra-Oxford vaccine, the first step in its plan to inoculate citizens in the country that’s home to the world’s second-largest Covid-19 outbreak.
|India Grants Emergency Approval to Astra-Oxford Covid Shot|
|U.K. May Tighten Curbs; U.S. Deaths Pass 350,000: Virus Update|
|More Than 12 Million Shots Given: Covid-19 Vaccine Tracker|
|Virus Tracker: Global Cases 84.7 Million; Deaths 1.84 Million|
Source: Read Full Article